| Ricardo Lafleur, MD | |
|
202 N Division St, Auburn, WA 98001-4939 | |
| (253) 545-2562 | |
| Not Available |
| Full Name | Ricardo Lafleur |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 20 Years |
| Location | 202 N Division St, Auburn, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932281250 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 60032720 (Washington) | Secondary |
| 208M00000X | Hospitalist | MD60037720 (Washington) | Primary |
| 207R00000X | Internal Medicine | MD60037720 (Washington) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Multicare Auburn Medical Center | Auburn, WA | Hospital |
| Tacoma General Allenmore Hospital | Tacoma, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Sound Inpatient Physicians Pllc | 5991618738 | 309 |
News Archive
Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, the Knight Cancer Institute at Oregon Health & Science University and The Leukemia & Lymphoma Society today announced that Aptose has joined the Beat AML collaboration.
The American Association of Clinical Endocrinologists (AACE) today released its first annual list of the most frequently searched endocrine medical conditions for 2013, as measured by visits to the organization's patient education website, www.empoweryourhealth.org.
AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced that the Defense Advanced Research Projects Agency (DARPA) has extended its contract with AnaptysBio to generate additional high affinity thermally stable antibodies for biodefense applications. This extension was awarded based upon the successful completion by AnaptysBio of milestones during the first year of the contract.
A clinical trial using genetic testing to match acute myeloid leukemia (AML) patients with new therapies is now open at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
› Verified 6 days ago
| Entity Name | Multicare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, the Knight Cancer Institute at Oregon Health & Science University and The Leukemia & Lymphoma Society today announced that Aptose has joined the Beat AML collaboration.
The American Association of Clinical Endocrinologists (AACE) today released its first annual list of the most frequently searched endocrine medical conditions for 2013, as measured by visits to the organization's patient education website, www.empoweryourhealth.org.
AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced that the Defense Advanced Research Projects Agency (DARPA) has extended its contract with AnaptysBio to generate additional high affinity thermally stable antibodies for biodefense applications. This extension was awarded based upon the successful completion by AnaptysBio of milestones during the first year of the contract.
A clinical trial using genetic testing to match acute myeloid leukemia (AML) patients with new therapies is now open at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
› Verified 6 days ago
| Entity Name | South Sound Inpatient Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023285756 PECOS PAC ID: 5991618738 Enrollment ID: O20031107000668 |
News Archive
Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, the Knight Cancer Institute at Oregon Health & Science University and The Leukemia & Lymphoma Society today announced that Aptose has joined the Beat AML collaboration.
The American Association of Clinical Endocrinologists (AACE) today released its first annual list of the most frequently searched endocrine medical conditions for 2013, as measured by visits to the organization's patient education website, www.empoweryourhealth.org.
AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced that the Defense Advanced Research Projects Agency (DARPA) has extended its contract with AnaptysBio to generate additional high affinity thermally stable antibodies for biodefense applications. This extension was awarded based upon the successful completion by AnaptysBio of milestones during the first year of the contract.
A clinical trial using genetic testing to match acute myeloid leukemia (AML) patients with new therapies is now open at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
› Verified 6 days ago
| Entity Name | Cogent Healthcare Of Washington, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861430522 PECOS PAC ID: 2062306350 Enrollment ID: O20040209000839 |
News Archive
Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, the Knight Cancer Institute at Oregon Health & Science University and The Leukemia & Lymphoma Society today announced that Aptose has joined the Beat AML collaboration.
The American Association of Clinical Endocrinologists (AACE) today released its first annual list of the most frequently searched endocrine medical conditions for 2013, as measured by visits to the organization's patient education website, www.empoweryourhealth.org.
AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced that the Defense Advanced Research Projects Agency (DARPA) has extended its contract with AnaptysBio to generate additional high affinity thermally stable antibodies for biodefense applications. This extension was awarded based upon the successful completion by AnaptysBio of milestones during the first year of the contract.
A clinical trial using genetic testing to match acute myeloid leukemia (AML) patients with new therapies is now open at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ricardo Lafleur, MD 202 N Division St, Auburn, WA 98001-4939 Ph: (253) 545-2562 | Ricardo Lafleur, MD 202 N Division St, Auburn, WA 98001-4939 Ph: (253) 545-2562 |
News Archive
Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, the Knight Cancer Institute at Oregon Health & Science University and The Leukemia & Lymphoma Society today announced that Aptose has joined the Beat AML collaboration.
The American Association of Clinical Endocrinologists (AACE) today released its first annual list of the most frequently searched endocrine medical conditions for 2013, as measured by visits to the organization's patient education website, www.empoweryourhealth.org.
AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced that the Defense Advanced Research Projects Agency (DARPA) has extended its contract with AnaptysBio to generate additional high affinity thermally stable antibodies for biodefense applications. This extension was awarded based upon the successful completion by AnaptysBio of milestones during the first year of the contract.
A clinical trial using genetic testing to match acute myeloid leukemia (AML) patients with new therapies is now open at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
› Verified 6 days ago
Jawaid Ahmad Behnawa, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 202 N Division St, Auburn, WA 98001 Phone: 253-545-2562 | |
Murad Y. Yunusov, MD,PHD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 202 N Division St, Auburn, WA 98001 Phone: 253-545-2562 |